Credit: Shutterstock photoBiotechnology stocks and exchange traded funds, such as the iShares Nasdaq Biotechnology ETF (NasdaqGM: IBB), are not often thought of as value plays. After all, biotechnology stocks historically trade at rich multiples relative to the broader healthcare sector and the overall equity market. The impact of a Trump presidency on healthcare stocks remains to be… Click to read more at ETFtrends.com.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
This article was provided by our partner Tom Lydon of etftrends.com.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
